Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

EDESA BIOTECH, INC. (EDSA) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

EDESA BIOTECH, INC. (EDSA), most recent 12 months reported: net loss $14.1M. From SEC filings. Others in Pharmaceutical Preparations: Dermata Therapeutics, Inc. · Design Therapeutics, Inc. · Dogwood Therapeutics, Inc. · Dyne Therapeutics, Inc. · Eledon Pharmaceuticals, Inc. · Elicio Therapeutics, Inc. · ENLIVEN THERAPEUTICS, INC. · ENVERIC BIOSCIENCES, INC.

Stock screener

Watchlist